Shekhar Gogna*

Resident General Surgery, Westchester Medical Center, Valhalla, New York, USA

*Corresponding Author: Shekhar Gogna, Resident General Surgery, Westchester Medical Center, Valhalla, New York, USA.

Received: May 22, 2017; Published: July 17, 2017

Citation: Shekhar Gogna. “Pathogenesis and Management Strategy for Docetaxel Induced Facial Nerve Paralysis”. Acta Scientific Cancer Biology 1.1 (2018).

Abstract

  Docetaxel is used as first line chemotherapy in head and squamous cell cancer. Peripheral sensory/motor neuropathy is a well- known side effect of docetaxel. We want to present a case of reversible docetaxel induced unilateral peripheral facial nerve palsy to identify this unique side effect.

Keywords: Docetaxel; Facial Nerve Palsy; Pathology; Management

Copyright: © 2018 Shekhar Gogna. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.